UroToday - Erectile Dysfunction (ED)

Home

Erectile Dysfunction (ED)

UroToday's Erectile Dysfunction section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of erectile dysfunction. Also available are conference coverage for all timely erectile dysfunction science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Erectile Dysfunction
UroToday International Journal

Display

results per page

Results 781 - 795 of 795

<< Start < Prev 51 52 53 Next > End >>

Antiretroviral Agents Associated with Sexual Dysfunction in HIV-infected Men
Tuesday, 12 November 2002
NEW YORK (Reuters Health) - Antiretroviral drugs, especially protease inhibitors (PIs), seem to be related to sexual dysfunction in men with HIV infection, according to a prospective analysis conducted in Spain. Neither hypophyseal hypogonadism nor testicular failure appears to play a part, according to the report in the November 1st issue of the Journal of Acquired Immune Deficiency Syndromes.
read more

Viagra Offers Blueprint for Rationing
Tuesday, 12 November 2002
NEW YORK (Reuters Health) - What four industrialized nations did to offset the financial threat posed by covering the erectile dysfunction (ED) treatment Viagra may serve as a blueprint for future coverage of so-called lifestyle drugs, a European research team reported on Tuesday.
read more

Tap Pharmaceutical Products Inc. Submits New Drug Application for UPRIMA® (Apomorphine HCL Tablets) Sublingual for Treatment of Erectile Dysfunction
Tuesday, 29 October 2002
LAKE FOREST, Ill., Oct. 29, 2002 - TAP Pharmaceutical Products Inc. announced today that it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration for UPRIMAÂ® (apomorphine HCl tablets) sublingual for the treatment of erectile dysfunction (ED). The NDA includes data for 2 mg and 3 mg doses.
read more

MacroChem Trials Halted by FDA on Carcinogenicity Fears
Monday, 14 October 2002
NEW YORK (Reuters Health) - MacroChem Corp. said on Friday that US regulators have halted trials of the firm's topical drugs containing SEPA because of concerns about the absorption-enhancer's potential to cause cancer.
read more

Vardenafil Shows Encouraging Results for Treatment of Erectile Dysfunction
Monday, 23 September 2002
LONDON (Reuters Health) - Most men treated with vardenafil (Levitra) for erectile dysfunction experienced markedly improved erections, according to results of phase III trials presented Monday at the World Congress of the International Society for Sexual and Impotence Research in Montreal.
read more

Beta-blocker-related Erectile Dysfunction Often Psychogenic
Thursday, 05 September 2002
BERLIN (Reuters Health) - Erectile dysfunction (ED) associated with beta-blocker use may in part be psychological and related to a general knowledge that the drugs are associated with such difficulties, according to research presented here at the European Society of Cardiology congress.
read more

Sildenafil may Improve Endothelial Function in Type 2 Diabetics
Friday, 30 August 2002
NEW YORK (Reuters Health) - In patients with type 2 diabetes, treatment with the anti-impotence drug sildenafil (Viagra) appears to improve flow-mediated dilatation (FMD), an index of nitric oxide-dependent endothelial function, according to a recent report.
read more

Diabetes Duration Influences Risk of Erectile Dysfunction
Thursday, 22 August 2002
NEW YORK (Reuters Health) - A longer duration of type 2 diabetes significantly enhances the already high risk of erectile dysfunction in men over 50, according to a report in the August issue of Diabetes Care.
read more

Sildenafil Effective for Erectile Dysfunction in CHF Patients
Tuesday, 06 August 2002
NEW YORK (Reuters Health) - Erectile dysfunction, which is common among patients with congestive heart failure (CHF), is treatable with sildenafil (Viagra) and also improves exercise capacity in these patients, according to the results of a randomized trial.
read more

New Intracavernous Therapy Safe and Well Tolerated by Men with ED
Wednesday, 19 June 2002
NEW YORK (Reuters Health) - PNU-83757, a novel erectogenic potassium channel opener, is safe and well tolerated in men with erectile dysfunction (ED), researchers report in the June issue of The Journal of Urology.
read more

Pfizer Loses UK Battle on Viagra Patent
Monday, 17 June 2002
LONDON (Reuters) - Pfizer Inc. has lost its final attempt to overthrow a British court ruling invalidating a UK patent on a key ingredient of its blockbuster impotence drug Viagra.
read more

Impotence Drug Tadalafil Demonstrates Long-lasting Effect
Friday, 31 May 2002
ORLANDO, Florida (Reuters Health) - Men with erectile dysfunction can have sexual intercourse for up to 36 hours after taking a single dose of the investigational phosphodiesterase inhibitor tadalafil (Cialis), according to study findings presented here at the American Urological Association's annual meeting.
read more

Gene Therapy May Restore Erectile Function
Wednesday, 29 May 2002
ORLANDO, Florida (Reuters Health) - Gene therapy may reverse the effects of aging on erectile dysfunction, suggest findings presented here Tuesday at the 100th annual meeting of the American Urological Association from a study conducted in rats.
read more

Vardenafil Said to Improve Erectile Function Regardless of Cause
Monday, 27 May 2002
FRANKFURT (Reuters Health) - Bayer's new anti-impotence drug vardenafil significantly improves erectile function irrespective of the cause of the problem, the company said in a statement at a US urological meeting at the weekend.
read more

Britain Pursuing More Rx-to-OTC Switches
Wednesday, 01 May 2002
LONDON (Reuters Health) - Britain said on Wednesday that it wanted to double the number of medicines available for sale over-the-counter without a prescription but cautioned that men wanting Viagra (sildenafil) should not hold their breath.
read more

Focus on Erectile Dysfunction

Focus on Erectile Dysfunction condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Effects of Once-Daily Tadalafil on Erectile Function in Men with Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia

- by Hartmut Porst, MD and Anne M. Wolka, PhD

Erectile Dysfunction Might Be Associated With Chronic Periodontal Disease: Two Ends of the Cardiovascular Spectrum

- by Yehuda Zadik, DMD, MHA

Tadalafil in the Treatment of Erectile Dysfunction

- by Robert M Coward, MD and Culley C Carson III, MD

Alcohol Consumption and Male Erectile Dysfunction: An Unfounded Reputation for Risk?

- by Kew-Kim Chew, MD

Early Endothelial Dysfunction as a Marker of Vasculogenic Erectile Dysfunction in Young Habitual Cannabis Users

- by Antonio Aversa, MD, PhD

Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer

- by Michael Pinkawa, MD

Erectile aid use by men treated for localized prostate cancer

- by Christopher P. Evans, MD, FACS

Simplified Approach for Correction of Congenital Penile Curvature

- by Tarek Salem, MD, et al.

Biochemical and Microanatomical Mechanism of Erectile Dysfunction

- by Arnold Melman, MD

Vasoactive Intestinal Polypeptide/Phentolamine for Intracavernosal Injection in Erectile Dysfunction

Phosphodiesterase Type 5 Inhibitors in the Management of Erectile Dysfunction Secondary to Treatments for Prostate Cancer: Findings from a Cochrane Systematic Review

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance

- by Christian P. Pavlovich, MD, et al.

Chronology of erectile function in patients with early functional erections following radical prostatectomy
- by John P. Mulhall, MD, et al.

Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men
- by Benson M. Hoffman, MD, et al.

Racial disparities in erectile dysfunction among participants in the California men's health study
- by James F. Smith, MD, MS, et al.

2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class
- by Alan W. Shindel, MD

Persistent erectile dysfunction following radical prostatectomy: The association between nerve-sparing status and the prevalence and chronology of venous leak
- by John P. Mulhall, MD, et al.

Penile rehabilitation and neuromodulation
- by Fernando Facio, MD and Arthur L. Burnett, MD

Toward a new 'EPOCH': Optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
- by Gerald Brock, MD, et al.

Erectile Function Recovery Rate after Radical Prostatectomy: A Meta-Analysis
- by John P. Mulhall, MD, et al.

Diabetes, Obesity, and Erectile Dysfunction
- by Ronald Tamler MD, PhD

Recovery of Erectile Function After Radical Prostatectomy is Quantitatively Related to the Response to Intraoperative Cavernous Nerve Stimulation
- by Farhang Rabbani, MD

The impact of preoperative erectile dysfunction on survival after radical prostatectomy
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of post radical prostatectomy erectile dysfunction
- Presented by David P. Wood, MD at the VI Maratona UrolÃ³gica

Advanced Techniques for Nerve Preservation
- Session Highlight by Ricardo SÃ¥nchez-Ortiz, MD from the 4th Annual World Robotic Urology Symposium (WRUS)

Premature Ejaculation: Advances in Definition, Pathophysiology and Pharmacology
- Multimedia Lecture presented by Dana A. Ohl, MD at the 33rd Winter Urologic Forum

Penile Trauma, Peyronieâ€™s Disease and Erectile Dysfunction
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Presented by Arnold Melman, MD at the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Podcast of the Presentation by Arnold Melman, MD at the AUA NY Section 2008

Assessment and Treatment of Erectile Function
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Penile Prostheses for the Treatment of Erectile Dysfunction
- Session Abstract written by Culley C. Carson, MD from the Masters in Urology 2008

Erectile Dysfunction and the Prostate: What are the Connections?
- Presented by Culley C. Carson, MD at the Masters in Urology 2008

Erectile Dysfunction After Plaque Incision and Grafting: Incidence and Predictors
- Session Highlight by Michael J. Metro, MD from the AUA 2008

Adult Stem Cell Therapy for Erectile Dysfunction
- Session Highlight by Christopher P. Evans, MD, FACS from the AUA 2008